Facephi Biometria's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 154.09.
Facephi Biometria's Days Inventory for the
six
months ended in Dec. 2025 was 0.
Facephi Biometria's Days Payable for the
six
months ended in Dec. 2025 was 228.35.
Therefore, Facephi Biometria's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was -74.26.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Facephi Biometria Cash Conversion Cycle Related Terms
Facephi Biometria Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Facephi Biometria's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:FACE vs CRM, SHOP, UBER: Cash Conversion Cycle Comparison
For the Software - Application subindustry, Facephi Biometria's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Facephi Biometria Cash Conversion Cycle vs Software Industry
For the Software industry and Technology sector, Facephi Biometria's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Facephi Biometria's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Facephi Biometria's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Facephi Biometria (XMAD:FACE) has a Cash Conversion Cycle of -74.26 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Facephi Biometria and its competitors.
Is Facephi Biometria's Cash Conversion Cycle too high?
Facephi Biometria's current Cash Conversion Cycle is -74.26. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's Cash Conversion Cycle compare to CRM and SHOP?
Facephi Biometria's Cash Conversion Cycle of -74.26 can be compared against companies in the Software industry. The industry median Cash Conversion Cycle is 32.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Software company?
The median Cash Conversion Cycle among Software companies is 32.53, based on 2,807 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Facephi Biometria and its competitors. For the Software industry, the median Cash Conversion Cycle is 32.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Facephi Biometria's current Cash Conversion Cycle is -74.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.91, compared to a current price of €2.04 — trading 29.9% below its estimated fair value. The current Cash Conversion Cycle is -74.26. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current Cash Conversion Cycle is -74.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?
Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued.
The current stock price of €2.04 is trading 29.9% below its estimated GF Value™ of €2.91.
GuruFocus considers Facephi Biometria to be Significantly Undervalued.
Key valuation signals for XMAD:FACE:
Cash Conversion Cycle: -74.26
GF Value™: €2.91 vs. price of €2.04 (29.9% below fair value)
No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score
Get the complete analysis for XMAD:FACE
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:FACE has been successfully added to your 
